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The purpose of this project was to investigate the role of the Checkpoint 
Suppressor 1 (Ches1) gene in mammalian development. The Ches1 gene 
belongs to the fork head transcription factor family and has been implicated in 
controlling the G2-M phase of the cell cycle in lower eukaryotes. Furthermore, 
Ches1 has been shown to bind the Sin3/Rpd3 HDAC complex in an inhibitory 
manner in yeast. I n human tumor cell lines, Ches 1 appears to negatively 
regulate gene expression through the recruitment of SKIP. While the functional 
role of Ches1 (Foxn3) in higher mammalian models is not well understood, it is 
under-expressed in both renal cell and oral squamous cell carcinomas. 
Our initial analysis indicates that we have generated Ches 1 mutant mice, 
and we plan to characterize the mutant mice for phenotypes that relate to 
developmental disorders as well as cancer formation. Our preliminary data 
suggests that loss of Ches1 results in embryonic lethality in mice. Our studies on 
the expression pattern of Ches1 in 11.5 days post coitum embryos show marked 
expression of Ches1 throughout the spinal cord. Observations of our Ches1 
mutant colony have resulted in the phenotypic characterization of distinct skeletal 
abnormalities in Ches1 heterozygotes. Future experiments will test our 
deduction of embryonic lethality, will further characterize Ches1 expression in 
embryonic development, and will address cancer susceptibility. 
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THE CELL CYCLE 
The cell cycle consists of four phases with the ultimate goal of replicating 
the genetic information encoded on the DNA and then segregating it equally into 
two daughter cells. The four phases are gap 1 (G1), synthesis (S), gap 2 (G2), 
and mitosis (M). 
Cells enter G1 after completion of a previous cycle. During this phase of 
variable length, the cell grows and proceeds through its normal metabolic 
functions. The cell subsequently proceeds to S phase, in which the DNA is 
replicated. Each chromosome replicates semi-conservatively to form two 
identical sister chromatids. After replication, sister chromatids remain attached to 
one another at the centromere via cohesin protein complexes. The kinetochore, 
a trilaminar structure composed of many proteins, is also formed at the 
centromere and functions to link the chromatids to spindle fibers later during 
mitosis. After S phase, the cell proceeds to G2, in which cell growth occurs in 
anticipation of division. 
Mitosis, or cell division, generates two daughter nuclei that are identical to 
the parent nucleus. Mitosis is divided into five continuous stages: prophase, 
prometaphase, metaphase, anaphase, and telophase. During prophase, the 
chromosomes condense, the two centrosomes move to opposite poles of the 
cell, and the mitotic spindle is formed as microtubules are synthesized from each 
centrosome. Prometaphase begins as the nuclear envelope disintegrates, which 
allows microtubules of the spindle to attach to the kinetochore of each chromatid. 
Each sister chromatid of one chromosome must attach to opposite poles for 
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proper orientation. During metaphase, the chromosomes become aligned at a 
midpoint known as the metapl1ase plate of the cell. After proper alignment and 
kinetochore attachment is achieved, anaphase occurs. During anaphase, the 
sister chromatids separate and move toward opposite poles of the cell. In 
telophase, nuclear envelopes reform around each of the two clusters of daughter 
chromosomes. Finally, cell division is completed by cytokinesis, the process that 
divides the cytoplasm into two distinct daughter cells, each containing a nucleus 
with identical chromosomes. 
Coordination of the stages and intricate processes in the cell cycle is 
driven by kinase complexes. The active form of these complexes consists of at 
least two proteins, the catalytic subunit known as a cyclin-dependent-kinase 
(CDK) and the regulatory subunit known as a cyclin (Hartwell and Kastan, 1994). 
These complexes undergo changes in the CDK and cyclin subunits that drive the 
cycle 'from one stage to another. In Saccharomyces cerevisiae, a single kinase, 
CDC28, interacts successively with a series of transiently expressed cyclins 
(Nasmyth, 1993). Each cyclin has a periodic spike in expression to drive a phase 
of the cell cycle, and the cyclin protein is rapidly degraded after translation 
(Molinari, 2000). The situation in mammalian cells is considerably more 
complicated as multiple CDK's and cyclins function to regulate cell cycle 
progression; however, the overall theme remains the same. 
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CELL CYCLE CHECKPOINTS 
Cell cycle checkpoints are mechanisms that ensure the order of events in 
the cell cycle and that integrate DNA repair with cell cycle progression (Hartwell 
and Kastan, 1994). These checkpoints make sure that progression to the next 
event occurs only after completion of a prior event in the cell cycle. If certain 
conditions have not been met or if DNA damage is present, the cycle will arrest 
at these checkpoints. 
There are four major areas of cell cycle control: the G1/S checkpoint, the 
intra-S phase checkpoint, the G2/M checkpoint, and the spindle checkpoint 
before anaphase in mitosis (Molinari, 2000). The G1/S checkpoint prevents the 
cell from replicating its DNA if any damage is present (Hartwell and Kastan, 
1994). In mammalian cells in G1, the dominant checkpoint response to DNA 
damage is the ATM(ATR}/CHK2(CHK1}-p53/MDM2-p21 pathway, which is 
capable of inducing sustained G1 arrest (Kastan and Lim, 2000). An arrest of the 
cell cycle may allow time for DNA repair or may commit a damaged cell to 
apoptosis (Weinert, 1998). 
The intra-S phase checkpoint is activated by genotoxic stress in the cell 
during replication. In the presence of such stress, the firing of origins of 
replication is inhibited in order to slow DNA synthesis (Kastan and Bartek, 2004). 
There are two parallel pathways to this checkpoint, both of which are controlled 
through ATM/ATR signaling (Kastan and Bartek, 2004). 
The G2/M checkpoint prevents progression into mitosis in the presence of 
either DNA damage or incompletely replicated DNA (Hartwell and Kastan, 1994). 
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In S. eerevisiae, the RAD9, RAD17, RAD24, MEC1 (a functional homologue of 
the human ATM gene), MEC2, and MEC3 gene products block mitosis in the 
presence of DNA damage or if replication is blocked in late S phase; MEC1 and 
MEC2 also prevent mitosis if replication is blocked in early S phase (Hartwell and 
Kastan, 1994). This pathway is not yet well understood in mammals. 
The spindle checkpoint ensures the integrity of segregation of sister 
chromatids in mitosis. This checkpoint prevents the onset of anaphase until the 
following prerequisites are achieved: assembly of a bipolar spindle, attachment of 
kinetochores of sister chromatids to spindle fibers emanating from opposite 
poles, and arrival of the attached chromosomes at the metaphase plate (Elledge, 
1996). While many of the details of this pathway are not yet understood, it is 
thought that a lack of tension at the kinetochore and/or an unattached 
kinetochore activates the checkpoint response (Amon, 1999). 
CHECKPOINT SUPPRESSOR 1 
CHES1 (Checkpoint suppressor 1; FOXN3) , a novel human cDNA, was 
first isolated as a high-copy suppressor of the S. eerevisiae G2/M checkpoint 
mutants rad9, mee1, rad24, rad53, and dun 1 (Pati et aI., 1997). CHES1 encodes 
a 490 amino acid member of the forkhead/winged helix family and has been 
mapped to a region between 14q24.3 and 14q31 (Pati et aI., 1997). 
The forkhead family is a large family of transcription factors that share a 
structurally related DNA binding domain: the forkhead. This domain is 
approximately 110 amino acids long, and it folds into a structure with three alpha 
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helices and three beta strands, which assemble into a compact hydrophobic core 
(Granadino et aI., 2000). Members of this family have been found in a wide 
range of species, with the exception of green plants (Granadino et aI., 2000). 
Forkhead proteins bind DNA as monomers and regulate transcription 
independently, either as activators or repressors . In some cases, however, they 
can also serve as transcriptionally inert docking factors for other proteins with 
transcriptional regulatory domains (Granadino et aI. , 2000). 
CHES1 belongs to the FOXN subfamily of forkhead transcription factors. 
This subfamily contains five members in addition to CHES1: FOXN1 (WHN) , a 
regulator of keratinocyte growth and differentiation of thymic epithelium (Coffer 
and Burgering, 2004); FOXN2 (human T-cell leukemia virus enhancer factor), 
which binds to the human T-cell virus long terminal repeat and may be involved 
in transcriptional regulation (Li et aI., 1992); and FOXN4-6, which have only 
recently been identified (Katoh and Katoh , 2004a-c). 
3' UTR 
(Llkb) 
eHES 1 (2.4kb) 
3' 

Figure 1. Schematic diagram of the full-length CHES1 cDNA (Pati et al., 1997) 
The CHES1 clone first isolated by the work of Pati et al. only encoded the 
carboxy terminus of the full protein , which lacks the forkhead DNA binding 
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domain (Fig. 1). This truncated cDNA conferred increased survival of the 
aforementioned G2/M checkpoint mutants after exposure to UV irradiation, 
ionizing irradiation, and methyl methane sulfonate (MMS) (Pati et aI., 1997). 
Furthermore, this suppression was accompanied by a reconstitution of a wild-
type G2 arrest after DNA damage in spite of mutations in essential checkpoint 
genes (Pati et aI., 1997). CHES1 was also able to suppress the null alleles of 
MEC1--which has been described as being essential for growth in the absence of 
DNA damage (Kato and Ogawa, 1994)-RA09, and OUN1 (Pati et al., 1997). 
Because the forkhead domain was not included in the truncated CHES1 clone 
used in these experiments, it does not appear that Ches1 induces new genes for 
restoration of the checkpoint. Pati et al. proposed that Ches 1 may activate an 




Figure 2. Possible mechanism of Ches1 action in cell cycle control (Pati et aI., 1997) 
In a study aimed at further elucidating information on the Ches1 
mechanism in yeast, the C-terminus of Ches1 was fused to glutathione s­
transferase (GST) in order to identify S. cerevisiae proteins that interact with the 
Ches1 in vivo (Scott and Pion, 2003). It was found that the Ches1 fusion protein 
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interacts with Sin3, a component of the Sin3/Rpd3 histone deacetylase complex 
(HDAC) in budding yeast (Scott and Pion, 2003). Rather than binding directly to 
DNA, the Sin3/Rpd3 HDAC complex is targeted to specific promoter regions via 
Sin3 interactions with site-specific DNA-binding proteins (Kadosh and Struhl, 
1997). 
The HDAC complex is a type of chromatin remodeling complex that 
removes acetyl groups on lysine residues of the amino-terminal ends of histones, 
particularly histones H3 and H4. The modulation of chromatin is a major route of 
gene regulation. Specifically, acetyl groups post-translationally added to these 
lysine residues neutralize the positive charge of the amino acid, which diminishes 
the electrostatic interaction of the histone with the negatively-charged DNA, 
thereby loosening chromatin structure (Neely and Workman, 2002). This 
loosening of chromatin structure by acetylation makes the DNA more accessible 
to transcriptional machinery for gene expression. Therefore, deacetylation via 
HDACs accomplishes the opposite: it restores the positive charge of the lysine 
residue to allow a stronger and tighter interaction between histone and DNA, 
effectively repressing transcription. 
In the study of Ches1 and Sin3 interaction, Ches1 did not suppress the 
DNA damage response in sin3 mutants, and over-expression of SIN3 blocked 
the Ches1-mediated G2 arrest after DNA damage (Scott and Plan, 2003). This 
evidence implies that the Ches 1 mechanism in suppressing S. cerevisiae 
checkpoint mutants and in restoring G2 arrest functions through the inhibition of 
Sin3/Rpd3 HDAC activity. By inhibiting this complex, target lysine residues 
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would remain acetylated and target gene expression would continue. This 
conclusion is consistent with prior work, which demonstrated that acetylation of 
H3 and H4 histone tails is necessary for the cell cycle transition of G2 to M phase 
in the absence of DNA damage (Howe et aI., 2001). Further investigation into 
the mechanism of DNA damage-induced arrest in both sin3 and rpd3 mutants 
revealed the dependency of the reconstituted G2/M arrest on the MAD1­
dependent spindle checkpoint pathway (Scott and Pion, 2003). 
Scott and Pion published a second study in 2005 on Ches 1 function in 
human cells. In this study, the C-terminus of Ches1 was shown to consistently 
repress transcription when targeted to a reporter promoter in cell lines derived 
from tumor tissues. Through screening of a cDNA library derived from fetal brain 
tissue and subsequent co-immunoprecipitation assays, Ches 1 was found to 
interact with SKIP (Ski -interacting protein) (Scott and Pion, 2005). SKIP is a 
well-conserved transcriptional adaptor protein that functions to recruit either 
activation or repression complexes to mediate multiple signaling pathways 
involved in the control of cell proliferation and differentiation (Dahl et aI., 1998). 
Specifically, Ches1 directly interacts with the hydrophobic C-terminus of SKIP (aa 
470-536), which defines a new region of SKIP protein-protein interaction (Scott 
and Pion, 2005). The findings in this study imply that Ches1 negatively regulates 
transcription through recruitment of SKIP. SKIP has been shown to bind the 
following repression complex members: mSin3a, HDAC1, and HDAC2 (Laduron 
et aI., 2004). This data is consistent with the finding that Ches1 inhibits the yeast 
orthologs of these proteins (Scott and Pion, 2003). 
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CHES1 AND CANCER 
In light of Ches1's involvement in suppressing checkpoint mutant 
phenotypes and in restoring G2 arrest after DNA damage in S. cerevisiae, we 
hypothesize that loss of Ches1 function will lead to higher cancer incidence in 
mammalian cells. The G2/M checkpoint functions to arrest the cell cycle in the 
presence of DNA damage or unreplicated DNA before entering mitosis. Loss of 
this control could allow a cell to enter mitosis with damage and pass its mutations 
on to its daughter cell(s). Incorporation of mutations can lead to loss of protein 
function and genetic instability, each of which make the cell more susceptible to 
further damage. Mutations of cell cycle checkpoint genes increase genetic 
instability and accelerate the process of cellular evolution toward the loss of cell 
cycle control, the hallmark of cancer (Hartwell and Kastan, 1994). 
Recent studies have shown CHES1 to be under-expressed in multiple 
tumor types. Struckmann et al. reported a 60% CHES1 expression frequency in 
normal renal tissue with only a 14% expression frequency in clear cell renal cell 
carcinomas (cRCC). CHES1 was also under-expressed in samples of oral 
squamous cell carcinoma (OSCC) as compared to normal tissues (Chang et aI., 
2005). Specifically, it was under-expressed in 46% of tumor samples studied, 
and, on average, its expression was decreased by 15.03-fold in OSCC cells 
(Chang et aI., 2005). Chang et al. also noted a correlation between the under­
expression of CHES1 and the expression of CDK1 in oral cancer samples, which 
they interpreted as an indication of a relationship between the regulatory 
mechanisms of the two genes. The down-regulation of CHES1 in malignant 
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tissues along with the finding that Ches1 recruits SKIP to repress transcription 
indicate that genes regulated by Ches1 may be over-expressed in cancerous 
cells due to decreased Ches1 levels (Scott and Pion, 2005). 
RESULTS AND METHODS 
Generation of Ches 1 Mouse Models 
In order to study the effects of a loss-of-function mutation of CHES1 in 
mammals, Ches1 deficient mice were generated by the following means. Murine 
embryonic stem (ES) cells with a gene-trap inserted into the Ches1 gene were 
obtained from the Mutant Mouse Regional Resource Center (MMRRC, UC­
Davis). A schematic of the Ches1 gene in Mus musculus is shown in Figure 3 
and a schematic of the gene-trap insertion is shown in Figure 4. The gene-trap 
has a strong splice acceptor site that disrupts the normal splicing of CHES1 
mRNA, which results in a non-functional, truncated Ches1 protein. The location 
of the trap was found to be downstream of exon 2 according to the automated 5' 
RACE annotation provided by tl1e MMRRC. 
These embryonic stem cells were used for blastocyst injections, and the 
resulting embryos were implanted into pseudo-pregnant females. The result of 
these transgenic embryos was the generation of chimeric mice. A chimera has 
some cells derived from the host's ES cells while other cells are derived from the 
transgenic ES cells (129 Ola/Hsd background), which in this case are the cells 
with Ches1 mutated. The chimeras were mated to c57/BL6 wild type female 
mice to ascertain whether the Ches1 mutant cells contributed to the germ line of 
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the chimeras. If they had, some of the resulting offspring would be heterozygous 
for Ches1 and would have an agouti coat color. Offspring of the chimera and 
wild type crosses were genotyped using peR (polymerase chain reaction) 
analysis, and heterozygous mice were bred to expand the colony. 
I I I I I I 
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Figure 4. Schematic representation of the gene-trap disruption of Ches1. 
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PCR Analyses and Genotyping 
Despite the 5'RACE confirmation of the location of the gene-trap provided 
by the Mutant Mouse Regional Resource Center, PCR analysis utilizing gene 
specific primers and trap specific primers have failed. We designed primers 
specific for intron 2 and the gene-trap to amplify a Ches1-gene-trap product that 
is expected in the heterozygous offspring. Analysis with at least a dozen 
different primer pairs spanning the whole of intron 2 did not provide any mutant 
specific PCR product. If the trap is inserted into the 46 kb-Iong intron 2, this 
problem may be due to the enormous size of the intron and/or the redundancy of 
intron sequences within the mouse genome. Furthermore, our experiments are 
based on a mouse genome database that is not completely curated. 
Consequently, our efforts in genotyping offspring of the founder mice have 
been limited to PCR amplification of gene-trap sequences using two gene-trap 
primers. While this analysis enables us to confirm the presence of the gene-trap 
within a mouse's genome, it does not enable confirmation of the location of the 
gene-trap within the Ches1 gene. Furthermore, gene-trap specific PCR analysis 
does not enable differentiation between Ches1 heterozygous and nullizygous 
mice. 
5'RACE: Rapid Amplification of cDNA Ends 
Due to unsuccessful efforts to design a PCR that will amplify a Ches1­
gene-trap product and due to a 1 % chance of clonal contamination, we employed 
5'RACE ( 5' Rapid 8mplification of ~DNA 1;nds) to confirm the presence of the 
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gene-trap in the Ches1 gene (Figure 5). Total RNA was isolated from the spleen 
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Figure 5. Overview of the 5'RACE Procedure (Invitrogen). 
Following isolation of total RNA, a reverse transcriptase reaction was 
carried out using a trap specific primer to synthesize cDNA from the trap locus to 
the 5' end of the transcript it's located on. After purification of the product, a 
homopolymeric tailing reaction was completed using terminal deoxynucleotidyl 
transferase (TdT) to add dC's to the 3'end of the newly synthesized cDNA. The 
dC tail creates a binding site for primers necessary to amplify the cDNA product. 
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Two subsequent PCR amplification reactions were carried out using primer pairs 
consisting of a trap primer and an anchor primer followed by agarose gel 
electrophoresis. Our analysis of the agarose gel electrophoresis of the 5'RACE 
reaction shows an 850 bp product (Fig. 6). The next step in confirming the 
location of the trap is to purify and 
sequence this identified fragment. 
ladder 5'RACE 
Figure 6. PCR amplification of 5'RACE product. 
Ches1 Expression in Development and Ches1 Phenotypes 
To investigate possible roles and expression patterns for Che's1 in mouse 
development, we used X-gal and the promoter-less ~-galactosidase-neomycin 
fusion construct (Fig. 4) to determine gene expression patterns in an 11.5 days 
post coitum (dpc) mating of a heterozygotic male to a wild type female (Fig. 7). 
Tissues with blue staining indicate expression of ~-Galactosidase from the gene 
Figure 7. Expression analysis of Ches1 in 11.5 dpc embryos. Whole embryos were 
stained with X-gal overnight to measure ~-galactosidase activity and photographed. 
Panel A is a control wild type embryo obtained from a Ches1 +/- cross to a wild type 
mouse. Panels Band C are stained whole mount Ches1 heterozygous embryos from the 
same mating. 
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trap, which is driven by the Ches1 promoter. As shown in Figures 7B and 7C, 
Ches1 expression was evident in the spinal cord of the heterozygous embryos. 
In phenotypic characterization of adult mice, our observations of Ches1 
heterozygotes have revealed distinct skeletal abnormalities. 
Analysis of Heterozygous Intercrosses 
Because of unsuccessful efforts to develop a PCR that will amplify a 
Ches 1-gene-trap product, we have been unable to genotypically differentiate 
between Ches1 heterozygous and nullizygous mice. Consequently, we can not 
definitively confirm whether the Ches1 nullizygous condition is embryonic lethal 
or not. However, through analysis of heterozygous intercrosses and the resulting 
offspring, the actual number of l1eterozygous/nullizygous offspring appears 
conspicuously low as compared to the expected number based on a Mendelian 
distribution (Table 1). This suggests embryonic lethality of the Ches1 nullizygous 
condition. Furthermore, our data shows that the average number of pups per 
litter of a wild type mating is between seven and eight. Based on Ches1 data 
from seven heterozygous intercrosses, the average number of pups per litter is 
approximately five. This further supports our conclusion that Ches1 is necessary 
for embryonic development. 
Table 1. Heterozygous 
intercross results. Genomic 
DNA samples obtained from 
tail clippings were analyzed by 
peR to determine their Ches1 
genotype. 
Results of Heterozygous Intercrosses 
Wild Type HetlNuli 
Actual Number 15 21 
Expected Number* 15 45 
*Based on a Mendelian distribution 
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Generation of Ches1 Deficient Cell Lines 
Mouse embryonic fibroblasts (MEFs) were obtained from a timed mating 
between a heterozygous male and a heterozygous female. Briefly, two 13.5 dpc 
embryos were harvested from the pregnant female and disaggregated using a 
syringe. The embryonic tissues were then plated onto 100 mm tissue culture 
plates and passaged upon confluency. These cell lines were maintained at 37°C 
using humidified air supplemented with 5% CO2 in DMEM with 15% fetal bovine 
serum and Penstrep. PCR amplification of a trap sequence using yolk sac 
samples genotyped both embryos as heterozygous (or possibly nullizygous) for 
Ches1. The cell line generated from the first embryo was later found to be 
contaminated. The second cell line was frozen in passage two until null and wild 
type cell lines are generated for comparison of cell growth kinetics. 
Future Work 
Further research on murine Ches1-deficient models is needed to expand 
our current understanding of Ches1's role in mammalian development and the 
cell cycle. To advance the data presented in this paper, we plan to examine 
embryonic expression data for Ches1 at 7.5,9.5, 13.5 and 15.5 dpc. This will 
allow for a more comprehensive perspective of the gene's role in development. 
To confirm the presence and locus of the gene-trap in Ches1, we will proceed 
with our 5'RACE analysis by sequencing the 850 bp product. Once data on the 
location of the trap is obtained, a PCR to amplify a Ches1-gene-trap product will 
be designed in order to differentiate between heterozygotes and nullizygotes. 
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This PCR will allow for the retro-analysis of DNA samples from our Ches1 colony 
to determine whether any nullizygous mice have been born of heterozygous 
intercrosses. If the results of said genotyping support our initial deduction that 
loss of Ches1 leads to embryonic lethality, we plan to determine the day and 
mechanism of embryonic lethality. Additionally, we intend to generate wild type 
and null cell lines in order to do cell growth kinetic experiments and cell cycle 
analyses for comparisons between the three genotypes. Upon Ches1 colony 
expansion, we will investigate organismal cancer susceptibility and relative life 
span. 
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